Hair loss is a symptom of many complex medical and psychological problems

Hair loss is a symptom, just like headache, diarrhoea or chest pain. It in the hands of dermatologist to individually evaluate each case, initiate an adequate diagnostic process and determine most suitable treatment. may be manifestation wide spectrum diseases conditions, ranging severity from mild transient, such as medication-induced telogen effluvium, severe life-threatening congenital acquired disorders. The general population exposed advertisements promoting miraculous products for ‘hair loss’, which can create false perception that ‘it only hair’. Additionally, medical term diseases’ misleading, it imply these affect hair shafts. August issue JEADV highlights some systemic causes scalp abnormalities, including lupus erythematosus, sclerosis, dermatomyositis, T cell B lymphomas, multiple myeloma metastases malignant tumours scalp. potential role trichoscopy suspecting different discussed details.1 One common leading women men androgenetic alopecia. Most patients have no evidence biochemical clinical hyperandrogenemia. However, cases, alopecia hormonal dysfunction. current features comprehensive review article describes therapeutic aspects associated with polycystic ovarian syndrome.2 authors emphasize crucial dermatologists not managing physical loss, but also addressing psychosocial consequences alopecia.3 Telogen effluvium common, yet relatively underexplored cause loss.4 has become topic several studies recently since post-COVID-19 symptom. Michelini et al.5 show two interesting effluvium. First, importance timing performing biopsy acute histological resolve over time. Secondly, shown presence fibrosis permanent loss. This finding raises questions about occurrence triggered by factors unrelated COVID-19. Alopecia areata autoimmune disease gained increased attention among dermatologists. With introduction JAK inhibitors, we are becoming first generation physicians who their dedicated group medications areata. there been growing concern serious adverse effects certain inhibitors elderly rheumatoid arthritis those smoke.6 Sechi al.7 conducted treatment safety found events infrequent, self-limited mostly moderate. Nonetheless, need collaborative registries long-term real-world settings. novel class medications, targeting dysregulated immune system areata, long-awaited many patients. focuses on burden this immune-mediated manifested well its strong association depression.8-10 was up 62% make significant life decisions relationships, education career based areata.8 Moreover, children adolescents often experience bullying, aggression.10 For us, our patients, goes far beyond ‘only (shafts)’.